LRH-1 spurs pancreatic cancer metastasis by enhancing the transcriptional activity of β-catenin and upregulates downstream targets (c-Myc, MMP2/9) (Lin et al., 2014a). Here, MMP2 is linked to pancreatic neoplasm.